216 related articles for article (PubMed ID: 23966413)
1. KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection.
Wang JM; Cheng YQ; Shi L; Ying RS; Wu XY; Li GY; Moorman JP; Yao ZQ
J Virol; 2013 Nov; 87(21):11626-36. PubMed ID: 23966413
[TBL] [Abstract][Full Text] [Related]
2. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.
Wijaya RS; Read SA; Schibeci S; Eslam M; Azardaryany MK; El-Khobar K; van der Poorten D; Lin R; Yuen L; Lam V; George J; Douglas MW; Ahlenstiel G
J Hepatol; 2019 Aug; 71(2):252-264. PubMed ID: 30905683
[TBL] [Abstract][Full Text] [Related]
3. KLRG1 impairs CD4+ T cell responses via p16ink4a and p27kip1 pathways: role in hepatitis B vaccine failure in individuals with hepatitis C virus infection.
Shi L; Wang JM; Ren JP; Cheng YQ; Ying RS; Wu XY; Lin SM; Griffin JW; Li GY; Moorman JP; Yao ZQ
J Immunol; 2014 Jan; 192(2):649-57. PubMed ID: 24337749
[TBL] [Abstract][Full Text] [Related]
4. Variation of human natural killer cell phenotypes with age: identification of a unique KLRG1-negative subset.
Hayhoe RP; Henson SM; Akbar AN; Palmer DB
Hum Immunol; 2010 Jul; 71(7):676-81. PubMed ID: 20394788
[TBL] [Abstract][Full Text] [Related]
5. CD56
Judge CJ; Kostadinova L; Sherman KE; Butt AA; Falck-Ytter Y; Funderburg NT; Landay AL; Lederman MM; Sieg SF; Sandberg JK; Anthony DD
J Leukoc Biol; 2017 Jul; 102(1):171-184. PubMed ID: 28400540
[TBL] [Abstract][Full Text] [Related]
6. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
[TBL] [Abstract][Full Text] [Related]
7. Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline.
Conry SJ; Meng Q; Hardy G; Yonkers NL; Sugalski JM; Hirsch A; Davitkov P; Compan A; Falck-Ytter Y; Blanton RE; Rodriguez B; Harding CV; Anthony DD
J Infect Dis; 2012 Apr; 205(7):1131-41. PubMed ID: 22351942
[TBL] [Abstract][Full Text] [Related]
8. Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.
Yoon JC; Lim JB; Park JH; Lee JM
J Virol; 2011 Dec; 85(23):12557-69. PubMed ID: 21937646
[TBL] [Abstract][Full Text] [Related]
9. CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C.
Kokordelis P; Krämer B; Boesecke C; Voigt E; Ingiliz P; Glässner A; Wolter F; Srassburg CP; Spengler U; Rockstroh JK; Nattermann J
J Acquir Immune Defic Syndr; 2015 Dec; 70(4):338-46. PubMed ID: 26509931
[TBL] [Abstract][Full Text] [Related]
10. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.
Golden-Mason L; Madrigal-Estebas L; McGrath E; Conroy MJ; Ryan EJ; Hegarty JE; O'Farrelly C; Doherty DG
Gut; 2008 Aug; 57(8):1121-8. PubMed ID: 18372499
[TBL] [Abstract][Full Text] [Related]
11. [Functional effects of killer cell lectin-like receptor subfamily G member 1 on natural killer cells in chronic hepatitis B infection].
Li MH; Zhang QF; Yin WW; Zhang DZ; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):585-589. PubMed ID: 30317789
[No Abstract] [Full Text] [Related]
12. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.
Ahlenstiel G; Titerence RH; Koh C; Edlich B; Feld JJ; Rotman Y; Ghany MG; Hoofnagle JH; Liang TJ; Heller T; Rehermann B
Gastroenterology; 2010 Jan; 138(1):325-35.e1-2. PubMed ID: 19747917
[TBL] [Abstract][Full Text] [Related]
13. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
[TBL] [Abstract][Full Text] [Related]
14. Interferon-γ production by tubulointerstitial human CD56
Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection.
Cheng YQ; Ren JP; Zhao J; Wang JM; Zhou Y; Li GY; Moorman JP; Yao ZQ
Immunology; 2015 Aug; 145(4):485-97. PubMed ID: 25772938
[TBL] [Abstract][Full Text] [Related]
16. Differential alteration of CD56(bright) and CD56 (dim) natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection.
Miyagi T; Shimizu S; Tatsumi T; Nishio K; Hiramatsu N; Kanto T; Hayashi N; Takehara T
J Gastroenterol; 2011 Aug; 46(8):1020-30. PubMed ID: 21559771
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of TIGIT and KLRG1 correlates with impaired CD56
Nie Y; Liu D; Yang W; Li Y; Zhang L; Cheng X; Chen R; Yuan B; Zhang G; Wang H
Virol J; 2022 Apr; 19(1):68. PubMed ID: 35413989
[TBL] [Abstract][Full Text] [Related]
18. Activation of natural killer cells during acute infection with hepatitis C virus.
Amadei B; Urbani S; Cazaly A; Fisicaro P; Zerbini A; Ahmed P; Missale G; Ferrari C; Khakoo SI
Gastroenterology; 2010 Apr; 138(4):1536-45. PubMed ID: 20080094
[TBL] [Abstract][Full Text] [Related]
19. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1).
Voehringer D; Koschella M; Pircher H
Blood; 2002 Nov; 100(10):3698-702. PubMed ID: 12393723
[TBL] [Abstract][Full Text] [Related]
20. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.
Bengsch B; Spangenberg HC; Kersting N; Neumann-Haefelin C; Panther E; von Weizsäcker F; Blum HE; Pircher H; Thimme R
J Virol; 2007 Jan; 81(2):945-53. PubMed ID: 17079288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
